Literature DB >> 12684635

Ionizing radiation and nitric oxide donor sensitize Fas-induced apoptosis via up-regulation of Fas in human cervical cancer cells.

In-Chul Park1, Sang-Hyeok Woo, Myung-Jin Park, Hyung-Chahn Lee, Su-Jae Lee, Young-Joon Hong, Seung-Hoon Lee, Seok-Il Hong, Chang-Hun Rhee.   

Abstract

Fas/CD95/Apo1 is a transmembrane receptor known to trigger apoptotic cell death in several cell types. In the present study, we showed that ionizing radiation (IR) and NO donor, S-nitroso-N-acetyl-penicillamine (SNAP), sensitized Fas-induced apoptotic cell death of HeLa human cervical cancers. Suboptimal dose of IR and SNAP up-regulated the cell-surface Fas antigen, detected by FACScan using FITC-anti-Fas antibody. When combined with IR or SNAP, agonistic anti-Fas antibody CH-11 resulted in marked enhancement of apoptosis. This sensitization was completely abrogated by anti-Fas neutralizing antibody ZB4. During the IR and SNAP sensitized Fas-induced apoptosis, mitochondria permeabilization, cytochrome c release, and DNA fragmentation were detected. Furthermore, combined treatment of IR and SNAP additively up-regulated the surface Fas protein expression and sensitized Fas-induced apoptosis. Our findings demonstrate that sensitization of HeLa cervical cells to Fas-mediated apoptosis by IR and NO donor is most likely due to the up-regulation of Fas expression and also provides a means with which to sensitize tumors to the killing effects of cancer therapy via the Fas receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684635

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

Review 1.  Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review).

Authors:  Abbas Salihi; Mohammed A Al-Naqshabandi; Zhikal Omar Khudhur; Zjwan Housein; Harmand A Hama; Ramyar M Abdullah; Bashdar Mahmud Hussen; Twana Alkasalias
Journal:  Mol Med Rep       Date:  2022-05-26       Impact factor: 3.423

Review 2.  NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action.

Authors:  Basil Rigas; Jennie L Williams
Journal:  Nitric Oxide       Date:  2008-04-29       Impact factor: 4.427

3.  The contribution of N₂O₃ to the cytotoxicity of the nitric oxide donor DETA/NO: an emerging role for S-nitrosylation.

Authors:  Ahlam A Ali; Jonathan A Coulter; Claire H Ogle; Marie M Migaud; David G Hirst; Tracy Robson; Helen O McCarthy
Journal:  Biosci Rep       Date:  2013-03-28       Impact factor: 3.840

4.  Up-regulation of Fas (CD95) expression in tumour cells in vivo.

Authors:  Naama Peshes-Yaloz; Dalia Rosen; Paul M Sondel; Peter H Krammer; Gideon Berke
Journal:  Immunology       Date:  2007-04       Impact factor: 7.397

Review 5.  The Role of Nitric Oxide in Cancer: Master Regulator or NOt?

Authors:  Faizan H Khan; Eoin Dervan; Dibyangana D Bhattacharyya; Jake D McAuliffe; Katrina M Miranda; Sharon A Glynn
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.